AppLovin Corporation (APP) Stock Forecast
Data as of Aug 1, 2026Technology · Current price $386.38 (-4.20%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 8, 2026 | Aaron Lee | Macquarie | $710.00 | +83.8% |
| Mar 2, 2026 | David Mak | Arete Research | $340.00 | -12.0% |
| Feb 12, 2026 | Michael Pachter | Wedbush | $640.00 | +65.6% |
| Feb 5, 2026 | Michael Pachter | Wedbush | $465.00 | +20.3% |
| Feb 4, 2026 | Matthew Cost | Morgan Stanley | $800.00 | +107.1% |
| Jan 14, 2026 | Robert Coolbrith | Evercore ISI | $835.00 | +116.1% |
| Jan 8, 2026 | Alec Brondolo | Wells Fargo | $735.00 | +90.2% |
| Dec 11, 2025 | James Heaney | Jefferies | $860.00 | +122.6% |
| Nov 6, 2025 | Nat Schindler | Scotiabank | $750.00 | +94.1% |
| Oct 14, 2025 | Eric Sheridan | Goldman Sachs | $630.00 | +63.1% |
| Oct 13, 2025 | Matthew Swanson | RBC Capital | $700.00 | +81.2% |
| Sep 26, 2025 | Chris Kuntarich | UBS | $810.00 | +109.6% |
| Sep 15, 2025 | Clark Lampen | BTIG | $664.00 | +71.9% |
| Jul 9, 2025 | Nat Schindler | Scotiabank | $430.00 | +11.3% |
| Jun 26, 2025 | James Callahan | Piper Sandler | $470.00 | +21.6% |
| Apr 23, 2025 | Mohammed Khallouf | HSBC | $436.00 | +12.8% |
| Mar 28, 2025 | Matthew Thornton | FBN Securities | $385.00 | -0.4% |
| Dec 5, 2024 | Scott Devitt | Stifel Nicolaus | $435.00 | +12.6% |
| Nov 27, 2024 | James Calla | Piper Sandler | $400.00 | +3.5% |
| Nov 11, 2024 | Rob Sanderson | Loop Capital Markets | $385.00 | -0.4% |
Top Analysts Covering APP
APP vs Sector & Market
| Metric | APP | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.07 | 2.36 | 2.42 |
| Analyst Count | 27 | 14 | 19 |
| Target Upside | +67.3% | +1911.8% | +17.1% |
| P/E Ratio | 33.19 | 37.64 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $7.89B | $8.05B | $8.22B | 21 |
| 2027-03-31 | $2.21B | $2.34B | $2.43B | 11 |
| 2027-06-30 | $2.33B | $2.47B | $2.57B | 7 |
| 2027-09-30 | $2.51B | $2.66B | $2.76B | 8 |
| 2027-12-31 | $2.85B | $3.02B | $3.14B | 7 |
| 2028-03-31 | $2.88B | $3.05B | $3.17B | 6 |
| 2028-06-30 | $3.02B | $3.21B | $3.34B | 6 |
| 2028-09-30 | $3.31B | $3.51B | $3.65B | 11 |
| 2028-12-31 | $3.80B | $4.03B | $4.19B | 6 |
| 2029-12-31 | $11.54B | $12.21B | $12.95B | 11 |
| 2030-12-31 | $12.83B | $13.57B | $14.39B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $14.57 | $15.66 | $17.55 | 17 |
| 2027-03-31 | $4.32 | $4.67 | $4.91 | 5 |
| 2027-06-30 | $4.56 | $4.92 | $5.18 | 5 |
| 2027-09-30 | $4.95 | $5.34 | $5.62 | 5 |
| 2027-12-31 | $5.83 | $6.30 | $6.62 | 5 |
| 2028-03-31 | $5.96 | $6.43 | $6.77 | 7 |
| 2028-06-30 | $6.20 | $6.69 | $7.04 | 6 |
| 2028-09-30 | $6.74 | $7.29 | $7.66 | 6 |
| 2028-12-31 | $7.98 | $8.62 | $9.07 | 7 |
| 2029-12-31 | $31.93 | $34.38 | $37.06 | 8 |
| 2030-12-31 | $0.00 | $0.00 | $0.00 | 12 |
Frequently Asked Questions
What is the analyst consensus for APP?
The consensus among 27 analysts covering AppLovin Corporation (APP) is Buy with an average price target of $659.88.
What is the highest price target for APP?
The highest price target for APP is $860.00, set by James Heaney at Jefferies on 2025-12-11.
What is the lowest price target for APP?
The lowest price target for APP is $14.00, set by Andrew Uerkwitz at Jefferies on 2022-11-30.
How many analysts cover APP?
27 analysts have issued ratings for AppLovin Corporation in the past 12 months.
Is APP a buy or sell right now?
Based on 27 analyst ratings, APP has a consensus rating of Buy (2.07/5) with a +67.3% upside to the consensus target of $659.88.
What are the earnings estimates for APP?
Analysts estimate APP will report EPS of $15.66 for the period ending 2026-12-31, with revenue estimated at $8.05B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.